Clinical trial
Sildenafil to Treat HIV-Associated Pulmonary Hypertension
NCT00327080 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Terminated
Key facts
| NCT number | NCT00327080 |
|---|---|
| Title | Sildenafil to Treat HIV-Associated Pulmonary Hypertension |
| Official title | Evaluation of Endothelial and Hemodynamic Function in HIV Associated Pulmonary Hypertension and a Phase I/II Safety and Efficacy Trial of Sildenafil in HIV Associated Pulmonary Hypertension |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV |
| Intervention type | Drug, Procedure |
| Interventions | MRI, L-NMMA, Acetylcholine |
| Enrollment | 20 |
| Start date | May 12, 2006 |
| Primary completion | Mar 18, 2009 |
| Completion | Mar 18, 2009 |
| First posted | May 18, 2006 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: